CN1183722A - 用于治疗人类疱疹-病毒-8的喷昔洛韦(Penciclovir)的应用 - Google Patents
用于治疗人类疱疹-病毒-8的喷昔洛韦(Penciclovir)的应用 Download PDFInfo
- Publication number
- CN1183722A CN1183722A CN96193793A CN96193793A CN1183722A CN 1183722 A CN1183722 A CN 1183722A CN 96193793 A CN96193793 A CN 96193793A CN 96193793 A CN96193793 A CN 96193793A CN 1183722 A CN1183722 A CN 1183722A
- Authority
- CN
- China
- Prior art keywords
- chemical compound
- treatment
- compositions
- molecular formula
- application
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Neurology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (9)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9504497.0 | 1995-03-07 | ||
GBGB9504497.0A GB9504497D0 (en) | 1995-03-07 | 1995-03-07 | Pharmaceuticals |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1183722A true CN1183722A (zh) | 1998-06-03 |
CN1138545C CN1138545C (zh) | 2004-02-18 |
Family
ID=10770731
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB961937939A Expired - Fee Related CN1138545C (zh) | 1995-03-07 | 1996-03-05 | 用于治疗人类疱疹-病毒-8的喷昔洛韦(Penciclovir)的应用 |
Country Status (23)
Country | Link |
---|---|
US (1) | US6489330B1 (zh) |
EP (1) | EP0814813B1 (zh) |
JP (2) | JPH11501625A (zh) |
KR (1) | KR19980702833A (zh) |
CN (1) | CN1138545C (zh) |
AT (1) | ATE254919T1 (zh) |
AU (1) | AU701739B2 (zh) |
BR (1) | BR9607663A (zh) |
CA (1) | CA2214406C (zh) |
CY (1) | CY2525B1 (zh) |
CZ (1) | CZ293470B6 (zh) |
DE (1) | DE69630876T2 (zh) |
DK (1) | DK0814813T3 (zh) |
ES (1) | ES2211949T3 (zh) |
GB (1) | GB9504497D0 (zh) |
HK (1) | HK1004373A1 (zh) |
HU (1) | HU226005B1 (zh) |
NO (1) | NO317733B1 (zh) |
NZ (1) | NZ303951A (zh) |
PT (1) | PT814813E (zh) |
TR (1) | TR199700921T1 (zh) |
WO (1) | WO1996027378A2 (zh) |
ZA (1) | ZA961795B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008036682A2 (en) | 2006-09-18 | 2008-03-27 | Raptor Pharmaceutical Inc. | Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates |
EP2274042A4 (en) * | 2008-04-11 | 2012-03-14 | Epiphany Biosciences Inc | TREATMENT AND / OR PREVENTION OF MULTIPLE SCLEROSIS |
US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3485225D1 (de) * | 1983-08-18 | 1991-12-05 | Beecham Group Plc | Antivirale guanin-derivate. |
EP0182024B1 (en) * | 1984-09-20 | 1991-04-03 | Beecham Group Plc | Purine derivatives and their pharmaceutical use |
DE3671227D1 (de) * | 1985-07-27 | 1990-06-21 | Beecham Group Plc | 9-substituierte guaninmonohydrate. |
CA2042931A1 (en) | 1990-05-24 | 1991-11-25 | Robert Zahler | Fluorinated bis (hydroxymethyl) cyclobutyl purines and pyrimidines |
GB9015051D0 (en) | 1990-07-07 | 1990-08-29 | Beecham Group Plc | Pharmaceutical treatment |
-
1995
- 1995-03-07 GB GBGB9504497.0A patent/GB9504497D0/en active Pending
-
1996
- 1996-03-05 CZ CZ19972831A patent/CZ293470B6/cs not_active IP Right Cessation
- 1996-03-05 CN CNB961937939A patent/CN1138545C/zh not_active Expired - Fee Related
- 1996-03-05 PT PT96907360T patent/PT814813E/pt unknown
- 1996-03-05 DK DK96907360T patent/DK0814813T3/da active
- 1996-03-05 WO PCT/EP1996/000933 patent/WO1996027378A2/en active IP Right Grant
- 1996-03-05 AU AU51022/96A patent/AU701739B2/en not_active Ceased
- 1996-03-05 JP JP8526607A patent/JPH11501625A/ja not_active Withdrawn
- 1996-03-05 ES ES96907360T patent/ES2211949T3/es not_active Expired - Lifetime
- 1996-03-05 HU HU9800272A patent/HU226005B1/hu not_active IP Right Cessation
- 1996-03-05 CA CA2214406A patent/CA2214406C/en not_active Expired - Fee Related
- 1996-03-05 AT AT96907360T patent/ATE254919T1/de not_active IP Right Cessation
- 1996-03-05 BR BR9607663A patent/BR9607663A/pt not_active Application Discontinuation
- 1996-03-05 TR TR97/00921T patent/TR199700921T1/xx unknown
- 1996-03-05 NZ NZ303951A patent/NZ303951A/xx not_active IP Right Cessation
- 1996-03-05 DE DE69630876T patent/DE69630876T2/de not_active Expired - Fee Related
- 1996-03-05 ZA ZA961795A patent/ZA961795B/xx unknown
- 1996-03-05 KR KR1019970706240A patent/KR19980702833A/ko not_active Application Discontinuation
- 1996-03-05 EP EP96907360A patent/EP0814813B1/en not_active Expired - Lifetime
-
1997
- 1997-09-05 NO NO19974101A patent/NO317733B1/no not_active IP Right Cessation
-
1998
- 1998-04-29 HK HK98103679A patent/HK1004373A1/xx not_active IP Right Cessation
-
1999
- 1999-12-29 US US09/473,888 patent/US6489330B1/en not_active Expired - Lifetime
-
2005
- 2005-05-26 CY CY0500032A patent/CY2525B1/xx unknown
-
2007
- 2007-08-08 JP JP2007206799A patent/JP2007297412A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR960000432B1 (ko) | 제약학적 생성물 | |
CN1138545C (zh) | 用于治疗人类疱疹-病毒-8的喷昔洛韦(Penciclovir)的应用 | |
US6136813A (en) | Pharmaceutical treatment | |
JP2008088189A (ja) | 潜伏ヘルペスウイルス感染の治療および予防のためのアミノプリン抗ウイルス剤の使用 | |
CN1071572C (zh) | 使用2-氨基嘌呤衍生物治疗和预防人类疱疹病毒7感染 | |
CN1084622C (zh) | 药物 | |
RU2293562C2 (ru) | Использование аминопуриновых противовирусных соединений для лечения и профилактики латентных инфекций, вызванных вирусом герпеса | |
CN1074925C (zh) | 2-氨基嘌呤衍生物在制造用于治疗和预防人类疱疹病毒6感染疾病的药物中的应用 | |
RU2181049C2 (ru) | Использование аминопуриновых противовирусных соединений для лечения и профилактики латентных инфекций, вызванных вирусом герпеса | |
KR100382707B1 (ko) | 잠재적허피스바이러스감염의치료및예방을위한아미노퓨린항바이러스제의용도 | |
MXPA97006759A (en) | Use of penciclovir for the treatment of herpes virus 8 hum | |
JPH10510278A (ja) | 潜伏ヘルペスウイルス感染の治療および予防のためのアミノプリン抗ウイルス剤の使用 | |
MXPA97004336A (en) | Use of antiviral agents for the treatment and prophylaxis of latent infections of herpesvi |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: BELLSOS INTELLECTUAL PROPERTY CO., LTD. Free format text: FORMER OWNER: SMITHKLINE BEECHAM PLC; SMITHKLINE BEECHAM CORP. Effective date: 20011206 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20011206 Address after: Hundred Hamilton Applicant after: Novartis Int Pharm Ltd. Address before: The British England Middlesex County Applicant before: Smithkline Beecham PLC Applicant before: Smithkline Beechan Corp. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20040218 Termination date: 20110305 |